ARTICLE | Company News
Alpha 1 Biomedicals deal
February 12, 1996 8:00 AM UTC
ALBM terminated its agreement to merge with Alpha 1 Acquisition Corp. (formerly Microbio Inc., a Castle Group company. See BioCentury Sept. 18) after determining that the company may be required to license a U.S. patent in order to commercialize Thymosin beta 4 to treat cystic fibrosis. ALBM is negotiating to obtain rights from the exclusive licensee of the patent. ...